Zimmer Biomet said that Persona OsseoTi Keel Tibia has secured the US Food and Drug Administration (FDA) 510(k) clearance for its use as a cementless knee replacement.
Persona OsseoTi is the latest addition to the US-based medical technology company’s Persona Knee system portfolio.
The system is said to have a new porous version of the Persona anatomic tibia that uses Zimmer Biomet’s OsseoTi porous medical technology to build a mimic structure of the architecture of human cancellous bone. For this, the technology combines anatomical data with 3D printing technology.
According to the medical technology firm, the material is combined with a keeled design to provide a stable initial and biological fixation.
Zimmer Biomet chief operating officer Ivan Tornos said: “With an increasing number of surgeons opting for cementless procedures for their patients, we are excited to expand our market-leading Persona Knee portfolio with the Persona OsseoTi Keel Tibia, a versatile and surgeon-centred solution for performing a cementless total knee replacement.
“Adding the Persona OsseoTi Keel Tibia to our well-established and clinically proven Persona Knee System allows surgeons to better address the needs of their patients with a comprehensive single system solution for a cementless or cemented application.
“We’re proud to close out the year with another advancement in our portfolio, thanks to the strong execution of our team members and our commitment to fuelling growth with innovation.”
Zimmer Biomet said that Persona OsseoTi offers less micromotion and optimal bone coverage by using an anatomic tibia. It also features a new cemented implant option to provide the surgeon with seamless versatility during the procedure.
In September this year, the company received the FDA 510(k) approval for its Identity Shoulder System. The Identity Shoulder System is designed for anatomic, reverse, and revision shoulder replacement.
